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CurrentConceptsReview
Lower Extremity-SpecificMeasures ofDisability
and Outcomes in Orthopaedic Surgery
Matthew V. Smith, MD, Sandra E. Klein, MD, John C. Clohisy, MD, Geneva R. Baca, BA,
Robert H. Brophy, MD, and Rick W. Wright, MD
Investigation performed at the Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri
 Outcome measures may be simple questions or complex measures that assess multiple interrelated domains
affecting treatment outcomes.
 Outcomemeasures should be relevant to patients, easy to use, reliable, valid, and responsive to clinical changes.
 Joint and disease-specific outcome measures have been developed for the hip, knee, and foot and ankle. Many of
these measures would benefit from further research into their validity, reliability, and optimal applicability.
 General health measures and activity level scores should be included in outcome assessments after treatment for
orthopaedic conditions.
When outcomemeasures were reported in the early orthopaedic
literature, simple metrics such as return to work and patient
satisfaction were used to judge the benefit of intervention for
patients. Although these simple metrics continue to be fre-
quently used and are useful1–5, more complex scoring systems
that assess multiple interrelated domains affecting outcomes,
such as pain, activities of daily living, and objective physical ex-
amination measures, have been developed. These more complex
measures may include physician-based assessments, patient-
based assessments, or both. They can be joint or disease-specific
or focus on general health6.
In general, outcomemeasures should be relevant to patients,
easy to use, reliable, valid, and responsive to clinical changes7. A
reliable outcomemeasure consistently gives the same results under
the same testing conditions. Establishing validity for an outcome
measure is a complex, multifactorial task that includes evaluation
of several facets, including construct validity (Does itmeasure what
it intends to?), criterion validity (Does it correlate to other valid
measures?), and content validity (Does it adequately assess the
critical features of the problem?). Therefore, the true validity of an
outcome is based on a body of evidence evaluating these many
facets of validity rather than on a single definitive test. Fur-
thermore, validating an instrument against another evaluates
only criterion validity, which does not assess whether the in-
strument measures what it intends to or adequately assesses the
critical features of the problem.
Responsiveness of an outcome measure is its ability to
detect changes in a clinical condition. The minimal clinically
important difference of an outcome measure is the smallest
change in an outcome score that corresponds to a change in a
patient’s condition8,9. If the minimal clinically important dif-
ference for an outcome measure is 15 points and a patient
records a 10-point change in that measure after treatment, the
patient may not note a true change in his or her actual clinical
condition. Lastly, outcome measures may have a so-called
ceiling effect (an inability to differentiate relatively good or
high outcomes) or a floor effect (an inability to differentiate
relatively low or poor outcomes). A floor effect occurs when a
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subject or a group of subjects performs poorly on an outcome
measure at baseline. Because of this poor performance, the
outcome measure may not be able to detect further deterio-
ration in their condition as the subjects already approach the
minimum score for that measure at baseline.
Our goal in this review is to outline the common out-
comemeasures used to report lower-extremity outcomes in the
orthopaedic literature. This is not a comprehensive or detailed
evaluation of each measure but rather an overview of why each
measure was developed, the conditions each has been reported
to assess, and the minimal clinically important difference if
available. In addition, general health (Short Form-36 [SF-36]
and SF-12) and general orthopaedic outcome measures (Mus-
culoskeletal Functional Assessment [MFA] and Short Muscu-
loskeletal Functional Assessment [SMFA]) are commonly used
in conjunction with specific lower-extremity outcome mea-
sures. These are summarized in Table I but are not included in
the discussion10–14. The lower-extremity outcome measures are
summarized in Table II (hip), Table III (knee), and Table IV
(foot and ankle).
Measure for Knee and Hip Osteoarthritis
Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC LK 3.0)
The Likert 3.0 version of the WOMAC (WOMAC LK 3.0) is
widely used and accepted as a disease-specific instrument
for osteoarthritis in the lower extremities and for evaluating
clinical outcomes after total hip replacement15. This is a self-
administered instrument with three subscales: pain (0 to 20
points), stiffness (0 to 8 points), and physical function (0 to 68
points). One total score (0 to 96 points) is also reported. There
are forty-one items with Likert scale responses from 0 to 4
points16,17. The scores are interpreted on a best-to-worst scale,
in which lower values indicate less pain and higher function.
The scores can be normalized, with 0 indicating severe symp-
toms and 100 indicating no symptoms and higher function.
Importantly, this normalization reverses the interpretation of the
score (a higher score indicates no symptoms and higher func-
tion). The WOMAC is sensitive to change and easy to use18–20;
therefore, it is the most commonly used disease-specific out-
come measure for osteoarthritis of the hip and knee18–20.
TheWOMAC has undergone rigorous validation and has
been used in more than sixty languages15,21–28, and it has been
validated against the SF-3629. Considering its focus on older
patients with osteoarthritis, it may not be appropriate for use in
a young and active population as it is likely to have ceiling
effects in this group. The minimal clinically important differ-
ence was reported to be 12% of the baseline score or 6% of the
maximum score in a study that examined rehabilitation in-
tervention in osteoarthritis18. A minimal clinically important
difference of 9 to 12 points (on a scale of 0 to 100) has also been
reported30.
Hip-Specific Outcome Measures
There exists an abundance of hip-specific clinical outcome
measures as recently summarized by Suk et al.31. Below is a
summary of the commonly used outcomemeasures for the hip.
Harris Hip Score
The Harris hip score was initially introduced in 1969 as a re-
search tool to assess the clinical results of mold arthroplasty for
traumatic hip arthritis32. This scoring system was formulated
to measure the important outcome variables applicable to
different hip disorders and treatment techniques. Pain (44
points), functional capacity (47 points), deformity correction
(4 points), and hip range of motion (5 points) are incorporated
into the maximum 100-point scoring system. A higher score in-
dicates higher function. Pain and functional capacity are heavily
weighted. The initial description did not specify whether the
questionnaire was clinician or patient-administered. This scoring
system is a commonoutcome tool for total hip arthroplasty and hip
joint preservation studies, and has been validated for arthroplasty
TABLE I General Health and General Orthopaedic Outcome Measures*
Responder Burden
(no. of questions) Target Population
Scale* Anatomic Region Measures Validated Clinician Patient Age (yr) Disorders MCID†
MFA10 General orthopaedic General health
and function






SMFA12 General orthopaedic General health
and function
Yes None 46 ‡18 Musculoskeletal
disorders
Unknown
SF-3613 General health General health Yes None 36 Any General health
SF-1214 General health General health Yes None 12 Any General health
*MFA =Musculoskeletal Functional Assessment, SMFA = Short Musculoskeletal Functional Assessment, and SF = Short Form.†MCID =minimal
clinically important difference.
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patients against the SF-36, WOMAC, Patient-Specific Index (PASI)
hip rating scale, and McMaster-Toronto Arthritis questionnaire
(MACTAR)29,33. The minimal clinically important difference is 4
points with an 8% change in score34.
The modified Harris hip score was developed in an at-
tempt to construct an outcome tool for more active patients35.
The questions on deformity correction (4 points) and the range
of motion (5 points) were removed, leaving a total of 91 po-
tential points for pain and function. This score is normalized to
100 by multiplying the raw score by 1.1. This score is most
commonly reported for hip-joint preservation surgery. The
modified score has not been validated. The minimal clinically
important difference is unknown.
Hip Disability and Osteoarthritis Outcome Score (HOOS)
The HOOS was developed to construct an instrument with
improved responsiveness compared with the WOMAC LK
3.036. This is a self-administered forty-item questionnaire with
a 5-point Likert scale used to assess five subscales (pain,
symptoms, activities of daily living, sport and recreation
function, and hip-related quality of life). All questions on the
WOMAC LK 3.0 are contained within the HOOS, and a
WOMAC score can be calculated. The additional HOOS
questions on sport and recreation function and hip-related
quality of life have been shown to be more responsive, espe-
cially in patients younger than sixty-six years. Each subscale is
scored separately and normalized to 100 points, with a higher
score indicating higher function. This score has been validated
relative to the SF-3636. The minimal clinically important dif-
ference is unknown.
High-Activity Hip Outcome
Measures Hip Outcome Score (HOS)
The HOSwas developed as an outcome instrument for patients
who underwent hip arthroscopy. This is a self-administered
questionnaire with two separately scored subscales: activities of
TABLE II Hip Outcome Measures for Patients with Osteoarthritis and Patients with a High Activity Level
Responder Burden
(no. of questions) Target Population





WOMAC15 Hip and knee Physical function,
pain, and stiffness









HHS32 Hip Pain, function,
deformity, and
range of motion























13–66 Labral tears and
hip arthroscopy
6–9


















Activity level Yes 10 10 58.4–65.8 Osteoarthritis Unknown
*WOMAC =Western Ontario and McMaster Universities Osteoarthritis Index, HHS = Harris hip score, HOOS = Hip Disability and Osteoarthritis Outcome Score, HOS = Hip Outcome
Score, MHHS = modified Harris hip score, and UCLA = University of California at Los Angeles. †MCID = minimal clinically important difference. ‡ADL = activities of daily living.
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daily living and sports. The activities of daily living subscale
contains nineteen items (seventeen scored), and the sports
subscale contains nine items pertaining to higher-level activi-
ties, such as those required in sports37,38. The HOS is reported
on a scale from 0 to 68 points or a scale from 0% to 100%, with
a higher score indicating better function38. In validity testing,
the HOS activities of daily living and sports subscales had a
high correlation to the SF-36 physical function subscale and
physical component summary score but a lower correlation to
the mental health subscale and mental component summary
score. The minimal clinically important difference is 6 to 9
points39.
Nonarthritic Hip Score
This self-administered questionnaire was developed for younger
patients with higher demands than older patients with arthritic
hip disease40. There are twenty questions (Likert scale responses
from 0 to 4), covering four domains, including pain, mechanical
symptoms, physical function, and activity level. The ten ques-
tions measuring pain and physical function come directly from
the WOMAC LK 3.0. The remaining questions focus on me-
chanical symptoms and levels of activity. The maximum score
of 100 indicates normal hip function. The score was initially
studied in a young patient cohort with an average age of thirty-
three years, and was validated against the Harris hip score and
the SF-1240. This outcome tool is designed for patients under-
going nonarthroplasty hip surgery. The minimal clinically im-
portant difference is unknown.
UCLA Activity Score
The UCLA (University of California at Los Angeles) activity
score was introduced as an activity measure for patients un-
dergoing total hip replacement and surface replacement ar-
throplasty41. This instrument evaluates patient activity with ten
TABLE III Knee Outcome Measures
Responder Burden







WOMAC15 Hip and knee Physical function,
pain, and stiffness






















Yes None 18 All knee
conditions
6.3 at 6 mo, and






Yes 3 2 Knee
replacement
Unknown




















14 at 6 mo, and








Yes None 32 ACL injuries Unknown
Tegner activity
scale59





Knee Activity level Yes None 4 All knee
conditions
Unknown
*WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index, KOOS = Knee Injury and Osteoarthritis Outcome Score, IKDC = International Knee Documentation
Committee, and ACL = anterior cruciate ligament. †MCID = minimal clinically important difference.
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descriptive activity levels (scored on a scale of 1 to 10). Activity
levels range from ‘‘wholly inactive’’ (1 point) to ‘‘regularly
participates in impact sports’’ (10 points). It has a low clinician
and patient burden, and is commonly used to analyze patient
activity level and return to sports after joint replacement and
joint preservation surgeries. The initial description was re-
ported in a study on patients who were fifty-eight to sixty-six
years old and did not specify whether the question was cli-
nician or patient-administered. The activity score has been
validated against quantitative assessment of walking activity
with a pedometer42. The minimal clinically important dif-
ference is unknown.
Knee-Specific Outcome Measures
Knee Injury and Osteoarthritis Outcome Score (KOOS)
On the basis of the perceived limitations of the use of the
WOMAC in young and active patients, the KOOS was created
as an extension of the WOMAC43. The KOOS is a patient-based
assessment graded on a 5-point Likert scale and is used to
evaluate outcomes after sports injuries44,45. It evaluates pain,
symptoms, activities of daily living, sport and recreation
function, and knee-related quality of life45. Like the WOMAC,
each subscale is summed to give a total score. The total score is
transformed to a scale from 0 to 100, with higher scores indi-
cating better outcome. All WOMAC questions are contained
within the KOOS so a WOMAC score can be calculated45. The
KOOS has been used for the assessment of a variety of diag-
noses46–50. The most sensitive subscales include the pain, sport
and recreation, and knee-related quality-of-life domains that
have the largest effect size in younger, more active patients26,46,49.
Although the minimal clinically important difference has not
been formally assessed, it has been estimated from theWOMAC
that a change of 8 to 10 points in a KOOS subscale is considered
clinically important.
International Knee Documentation Committee (IKDC)
Subjective Knee Form
The IKDCwas established in 1987, and the IKDC formwas first
published in 1993 as a standardized method to evaluate knee
injuries and treatment. In 1997, the Board of the American
Orthopaedic Society for Sports Medicine revised the form to
become a knee-specific assessment tool rather than a disease
and/or condition-specific tool51. The result was an eighteen-
question patient-rated form that evaluates symptoms, func-
tion, and sports activity. The raw scores are summed and
transformed to a scale from 0 to 100, with higher scores rep-
resenting better outcomes51. The IKDC subjective form has
been validated and shown to be reliable and responsive for a
wide range of knee conditions52,53. The strength of the IKDC
form is that it can be used as a single form to assess any con-
dition involving the knee and thus allow comparison between
groups with different diagnoses. In a study including a wide
variety of knee conditions, a minimal clinically important
difference of 11.5 points on the 100-point scale was sensitive
to change in a condition53. The minimal clinically important
difference of the IKDC subjective form after treatment of
TABLE IV Foot and Ankle Outcome Measures
Responder Burden




















Midfoot Pain and function
(change after
intervention)











No 5 3 Forefoot
conditions
Unknown
FAAM93 Foot and ankle Patient-reported
function
Yes None 29 All foot
and ankle
8 on ADL,
and 9 on sports
subscales




AOS88 Ankle Pain and disability Yes None 18 Ankle arthritis Unknown
Mazur Ankle
Score111






VISA-A85 Achilles tendon Pain and function
(daily living and
sports activities)
Yes None 8 Achilles
tendinopathy
Unknown
*AOFAS = American Orthopaedic Foot & Ankle Society, MTP =metatarsophalangeal, IP = interphalangeal, FAAM = Foot and Ankle Ability Measures, FFI = Foot Function Index, AOS =
Ankle Osteoarthritis Score, and VISA-A = Victorian Institute of Sports Assessment-Achilles. †MCID = minimal clinically important difference, and ADL = activities of daily living.
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articular cartilage injury is 6.3 at six months and 16.7 at twelve
months54.
American Knee Society Score
The American Knee Society Score was developed in 1989 to assess
the results of knee replacement and consists of two parts: (1) a
knee score that evaluates pain, stability, and range ofmotion of the
knee (three items) and (2) a function score that mainly assesses
walking distance and stair-climbing (two items)55. Each portion is
scored from 1 to 100, with higher scores indicating better out-
come. It has been criticized as a surgeon-assessed score that in-
troduces potential bias. It has been validated and noted to be
responsive56,57. Although it is used traditionally for knee arthro-
plasty, it has also been used to assess patients with osteoarthritis
who are not undergoing knee replacement. Theminimal clinically
important difference is unknown.
Lysholm
The Lysholm score was published in 1982 andmodified in 1985 to
evaluate outcomes after knee ligament surgery with an emphasis
on the assessment of instability symptoms58. The Lysholm score is
a questionnaire consisting of eight items: (1) pain, (2) instability,
(3) locking, (4) squatting, (5) limp, (6) support, (7) swelling, and
(8) stair-climbing. Each item is assigned a maximum numerical
value, with pain and instability carrying the highest weight. The
score is summed to give a number between 0 and 100 points58,59.
The scores are arbitrarily categorized as excellent (95 to 100), good
(84 to 94), fair (65 to 83), and poor (<65)60.While the Lysholmhas
been widely used to measure outcomes for knee ligament sur-
gery60, it has received criticism that it functions better for patients
after an anterior cruciate ligament (ACL) reconstruction than for
those with other knee conditions61,62. Its validity, sensitivity, and
reliability have been called into question4,61,62. In addition, the
Lysholm scoring systemmay have a ceiling effect since scores tend
to be higher compared with other knee outcome measures. The
Lysholm score continues to have value, especially for comparison
with older literature, given the wide use of the score. It may be of
greater value when used in conjunctionwith other scores andwith
an activity scale, which may adjust for the ceiling effect. The
minimal clinically important difference is unknown.
Cincinnati Knee Rating System
In 1983, the Cincinnati Knee Rating System was described to
assess subjective symptoms and activity level63,64. Since its
original description, it was modified to evaluate thirteen scales
and then refined to include six subscales: (1) symptoms (20
points), (2) daily and sports activities (15 points), (3) physical
examination findings (25 points), (4) stability (20 points), (5)
radiographic findings (10 points), and (6) functional testing
(10 points)65. The measure is scored on a 100-point scale, with
higher scores indicating better outcomes. It has been validated to
assess outcomes of ACL injury and reconstruction4,65. It is
comprehensive and has undergone rigorous assessment66,67.
The Cincinnati Knee Rating System scores may be lower com-
pared with other outcome measures that assess the same con-
dition66,67. This rating system is responsive to clinical change68.
The minimal clinically important difference of the Cincinnati
Knee Rating System after treatment of articular cartilage injury is
14 at six months and 26 at twelve months54.
ACL Quality of Life
In 1998, this score was established as a disease-specific measure
of chronic ACL deficiency69. There are thirty-two items that
evaluate, with use of a visual analog scale, physical complaints,
work-related concerns, recreational activities and sport partici-
pation or competition, lifestyle, and social and emotional func-
tion. The total score is transformed to a scale from 0 to 100 points
with each item weighted equally, with higher scores indicating a
better outcome. It has been shown to be valid, reliable, and re-
sponsive to clinical change69. The minimal clinically important
difference is unknown.
Tegner Activity Scale
First published in 1985, the Tegner activity scale was designed
to give an objective numerical value to assess a patient’s activity
level59. On a scale from 0 to 10, a score of 0 represents disability
secondary to knee problems. Scores between 1 and 5 represent
activity levels consistent with work or recreational sports,
ranging from sedentary jobs through heavy manual labor.
Scores of >5 represent higher-level recreational and competitive
sports. A score of 10 was assigned to national or international-
level soccer. This scale relates activity to specific sports rather
than to the specific skills required to participate in those sports.
Thus, it is difficult to apply to all patients across different sports.
Formal validation has not been performed. The minimal clini-
cally important difference is unknown.
Marx Activity Scale
TheMarx activity scale was developed to create a short, patient-
based activity assessment that uses questions designed to assess
specific functional activities70. It evaluates the patient’s level of
activity in terms of running, cutting, decelerating, and pivot-
ing. Designed to assess the patient’s highest peak activity over
the last year, it consists of four questions that are scored from 0
to 4 on the basis of how often the activity is performed. Vali-
dated during its development, the scale is easy to use with
minimal responder burden. The minimal clinically important
difference is unknown.
Foot and Ankle-Specific Outcome Measures
Over sixty outcome and clinical rating systems have been de-
scribed for conditions of the foot and ankle71. Many instruments
are disease-specific and useful only in evaluating outcomes after
treatment of conditions such as rheumatoid arthritis72–76, ankle
instability77–83, Achilles tendon disorders84,85, arthritis86–88, and
calcaneal fractures89,90. Below are the instruments specific to the
foot and ankle region that are more widely applicable and more
frequently used in outcomes research73,91-93.
American Orthopaedic Foot & Ankle Society (AOFAS) Scales
The AOFAS rating system was initially developed by the AOFAS
to report clinical status for any foot or ankle disorder. There are
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four separate instruments specific to regions of the foot and
ankle: the ankle-hindfoot, midfoot, hallux metatarsophalangeal-
interphalangeal, and lesser metatarsophalangeal-interphalangeal
scales92. The scales contain both clinician-based (range of mo-
tion, alignment, gait, and stability) as well as patient-based items
(pain, function, walking distance and surfaces, and shoe wear) in
three subscales with a maximum score of 100 points, with a
lower score corresponding to greater disability. The AOFAS
scales have shown low levels of validity when evaluated against
SF-36, QALY (quality-adjusted life-year) scores, or the Foot
Function Index (FFI)94–97. Despite their limitations, they remain
some of the most commonly used outcome instruments for the
foot and ankle98,99. Baumhauer et al. found the hallux and lesser
toe instruments reliable in a group of patients with rheumatoid
arthritis but did not establish validity of the scales100. The AOFAS
scales have been established as responsive to change after in-
tervention for foot and ankle conditions and are commonly used
for this purpose101. The minimal clinically important difference
is unknown.
Foot and Ankle Ability Measure (FAAM)
The FAAM was developed to address the need for a universal,
validated instrument for the foot and ankle93. It is a patient-
reported assessment used to evaluate outcomes and health
status in patients with foot or ankle disorders93. The two sub-
scales, activities of daily living and sports, are included with
twenty-nine items, which are transformed to a score of 0
(greatest disability) to 100 (least disability). Validation studies
have been performed for a general population of patients with
foot and ankle disorders, a group of patients with diabetes
mellitus, and athletes with chronic ankle instability93,102,103. This
instrument is the most extensively validated foot and ankle
outcome instrument available, with a minimal clinically im-
portant difference of 8 on the activities of daily living subscale
and 9 on the sports subscale93. The score is sensitive to overall
health status and comorbidities. However, limitationsmay exist
in its use with higher-functioning patients because of a po-
tential for a ceiling effect.
Foot Function Index (FFI)
The FFI is a patient-reported assessment tool to measure the
impact of pain, disability, and activity restriction related to foot
and ankle disorders in patients with rheumatoid arthritis73. The
initial validation studywas performed in a group of patients with
rheumatoid arthritis, and further reliability testing has been
performed in a general population of patients with a foot dis-
order73,76,104,105. The measure contains twenty-three items in three
subscales that are scored to a maximum of 100 points. The items
are scored on a visual analog scale, and a higher score indicates
greater disability. This measure is a useful index for outcomes in
patients with rheumatoid arthritis. Efforts to expand the use of
the instrument have resulted in several modified versions (the
FFI-5pt75, FFI Revised, and FFI short form)106. While the FFI-5pt
(the FFI with verbal rating scales) correlated well with the
original FFI, the modified versions have not been used exten-
sively. The minimal clinically important difference is unknown.
Ankle Osteoarthritis Score (AOS)
The AOS is a patient-reported, disease-specific assessment that
was developed from a modification of the FFI and is used to
measure pain and disability related to osteoarthritis of the
ankle88,107,108. It has also been used as an outcome measure after
treatment of tibial plafond fractures109,110. The score is com-
posed of two subscales (pain and disability) with eighteen items
scored on a 10-cm visual analog scale, with a maximum score
of 100 points. A higher score indicates greater disability. Vali-
dation studies indicate high levels of test-retest reliability and
criterion and construct validity compared with the SF-36 and
WOMAC88. While this remains the only validated disease-
specific instrument for ankle osteoarthritis, the primary limi-
tation of the score is its limited applicability to a large number
of foot and ankle disorders. The minimal clinically important
difference is unknown.
Mazur Ankle Score
TheMazur ankle score is a clinician-based outcome instrument
derived from the Harris hip-scoring system that is used to
evaluate outcome after ankle arthrodesis111. Pain, function, and
range-of-motion subscales are rated with a twelve-item in-
strument and a total possible score of 100 points. Results
correlate well with successful ankle fusion on radiographs, with
higher scores indicating a better outcome. Scores of >60 are
associated with patient satisfaction112. This instrument has been
primarily used in the evaluation of outcome after ankle ar-
throdesis and tibial plafond fractures113,114. It is limited in use
because of the disease-specific development of the tool. The
minimal clinically important difference is unknown.
Victorian Institute of Sport Assessment-Achilles
Questionnaire (VISA-A)
The VISA-A is a patient-reported instrument that measures the
clinical severity of Achilles tendinopathy85,115. The tool is com-
posed of three subscales with eight items rating pain, activity, and
functional status. The maximum score is 100 points, with a lower
score indicating greater disability. The tool is useful in rating
the clinical severity of Achilles tendinopathy for use in medical
decision-making and has been validated against the grade of se-
verity described by Percy and Conochie115, the grade of severity
described by Curwin and Stanish116, and the Achilles tendinop-
athy range of severity85,117. It has not been validated in the mea-
surement of clinical outcome after surgery. This instrument is
also limited in its applicability to other disorders of the Achilles
tendon. The Achilles tendon total rupture score was developed
on the basis of the VISA-A to assess outcome after Achilles tendon
rupture84. Theminimal clinically important difference is unknown.
Discussion
Orthopaedic surgery has lagged behind othermedical and surgical
specialties in developing and using outcome measures to study
factors that influence the outcomes after treatment118. In general,
outcome measures for the lower extremity can be useful, but they
vary widely in terms of what is known about their validity, reli-
ability, minimal clinically important difference, and applicability
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to specific patient populations. It is important to understand how
and why these instruments were developed, what they are vali-
dated to assess, and how thesemeasures respond to clinical change
to avoid misinterpreting reports of patient outcomes.
Investigators performing clinical research should choose
measures that have been validated for the disease and/or joint
in question. Investigators should also attempt to use instru-
ments that have a reported minimal clinically important dif-
ference for ease of interpreting important changes in scores.
Furthermore, when choosing outcome measures for clinical
research, there is rarely a single most appropriate rating system.
Studies should include a measure of general health and an
activity scale since rating of disability and outcomes is often
affected by psychological and sociological factors that are not
accounted for in joint-specific measures. This provides better
characterization of patient populations and screens for differ-
ences that may influence outcomes. For example, outcomes
after an operative intervention in a sedentary patient with
multiple medical comorbidities may be affected by health sta-
tus compared with the same surgical procedure in an active
and healthy person. Rigorous outcomes assessment requires a
combination of general health measures, activity scales, and
condition-specific measures. Lastly, investigators should strive
to balance the utility of collecting and analyzing data from
multiple outcome instruments with the burden to responders
when completing the forms.
In summary, there are a number of clinical outcome mea-
sures available for the lower extremity,many of which could benefit
from further research into their validity, reliability, and optimal
applicability. Investigators should use outcome measures that are
valid, reliable, and responsive for assessing the condition being
studied. In addition, reviewers and readers should critically eval-
uate the measures that are used in clinical studies. By increasing
their familiarity with these instruments, orthopaedic surgeons are
better equipped to design studies of lower-extremity disorders,
interpret the data appropriately, and implement the findings into
their practices on the basis of sound and informed judgment. n
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